Colorectal Cancer Clinical Trials in Colorado

Showing 21-40 of 223 trials

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

NCT04963283

Data from a prior phase II study of single agent cabozantinib in metastatic, refractory colorectal cancer (NCT03542877) combined with the compelling preclinical data in colorectal mouse models utilizing cabozantinib combined with nivolumab have led to this concept for a clinical trial to combine cabozantinib and nivolumab in patients with metastatic MSS CRC in the third line setting and beyond.

Colorectal AdenocarcinomaColon CancerColon Adenocarcinoma+4 more

University of Colorado, Denver48 participantsStarted Jun 2021

Aurora, Colorado, United States • Colorado Springs, Colorado, United States • Fort Collins, Colorado, United States +2 more locations

RECRUITINGNA31 miles

Improving Care for Rural Patients With Solid Tumors

NCT04916990

This study will assess if the CARES (Cancer Advocacy, Resources, Education and Support) intervention improves time to start of treatment after diagnosis and time to treatment completion for solid tumors (ex: lung, head, neck, thyroid, cervical, breast, bladder, colon, and rectal cancers) in rural patients.

Lung CancerHead and Neck CancerThyroid Cancer+5 more

University of Colorado, Denver320 participantsStarted Sep 2022

Aurora, Colorado, United States • Colorado Springs, Colorado, United States • Colorado Springs, Colorado, United States +11 more locations

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

Improving Care for Rural Patients With Solid Tumors

Colorectal Cancer Trials in Other Cities

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

GCC19CART for Patients With Metastatic Colorectal Cancer

Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

ColoSeal™ ICD System Anastomotic Protection Pivotal Study

A Study of MGC026 in Participants With Advanced Solid Tumors

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

A Study of PHN-010 in Patients With Advanced Solid Tumors

Early Onset Colorectal Cancer Detection

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Other Conditions in Colorado